112 related articles for article (PubMed ID: 9561317)
1. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
Murphy BE; Ghadirian AM; Dhar V
Can J Psychiatry; 1998 Apr; 43(3):279-86. PubMed ID: 9561317
[TBL] [Abstract][Full Text] [Related]
2. Response to steroid suppression in major depression resistant to antidepressant therapy.
Murphy BE; Dhar V; Ghadirian AM; Chouinard G; Keller R
J Clin Psychopharmacol; 1991 Apr; 11(2):121-6. PubMed ID: 1829098
[TBL] [Abstract][Full Text] [Related]
3. Antiglucocorticoid therapies in major depression: a review.
Murphy BE
Psychoneuroendocrinology; 1997; 22 Suppl 1():S125-32. PubMed ID: 9264159
[TBL] [Abstract][Full Text] [Related]
4. Theoretical basis for response to steroid suppression in major depression.
Rothschild AJ; Schatzberg AF
J Clin Psychopharmacol; 1992 Apr; 12(2):142-4. PubMed ID: 1573041
[No Abstract] [Full Text] [Related]
5. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
6. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
[TBL] [Abstract][Full Text] [Related]
7. Treatment of major depression with steroid suppressive drugs.
Murphy BE
J Steroid Biochem Mol Biol; 1991 Aug; 39(2):239-44. PubMed ID: 1888684
[TBL] [Abstract][Full Text] [Related]
8. Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication.
Takebayashi M; Kagaya A; Uchitomi Y; Kugaya A; Muraoka M; Yokota N; Horiguchi J; Yamawaki S
J Neural Transm (Vienna); 1998; 105(4-5):537-42. PubMed ID: 9720981
[TBL] [Abstract][Full Text] [Related]
9. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
van den Bosch OF; Stades AM; Zelissen PM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles.
Raven PW; O'Dwyer AM; Taylor NF; Checkley SA
Psychoneuroendocrinology; 1996 Apr; 21(3):277-86. PubMed ID: 8817726
[TBL] [Abstract][Full Text] [Related]
11. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
Bschor T; Adli M; Baethge C; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M
Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
[TBL] [Abstract][Full Text] [Related]
12. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
Thakore JH; Dinan TG
Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
[TBL] [Abstract][Full Text] [Related]
13. The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.
Ghadirian AM; Engelsmann F; Dhar V; Filipini D; Keller R; Chouinard G; Murphy BE
Biol Psychiatry; 1995 Mar; 37(6):369-75. PubMed ID: 7772645
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?
Kling MA; Coleman VH; Schulkin J
Depress Anxiety; 2009; 26(7):641-9. PubMed ID: 19133699
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone suppression test and selection of antidepressant medications.
Greden JF; Kronfol Z; Gardner R; Feinberg M; Mukhopadhyay S; Albala AA; Carroll BJ
J Affect Disord; 1981 Dec; 3(4):389-96. PubMed ID: 6459354
[TBL] [Abstract][Full Text] [Related]
16. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
17. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
19. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.
Yamaoka M; Hara T; Hitaka T; Kaku T; Takeuchi T; Takahashi J; Asahi S; Miki H; Tasaka A; Kusaka M
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003
[TBL] [Abstract][Full Text] [Related]
20. Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.
Bruning PF; Bonfrer JM; De Jong-Bakker M; Nooyen W
J Steroid Biochem; 1984 Sep; 21(3):293-8. PubMed ID: 6092781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
